Differences between culture & non-culture confirmed invasive meningococci with a focus on factor H-binding protein distribution

被引:7
作者
Clark, Stephen A. [1 ]
Lekshmi, Aiswarya [1 ]
Lucidarme, Jay [1 ]
Hao, Li [2 ]
Tsao, How [2 ]
Lee-Jones, Lisa [3 ]
Jansen, Kathrin U. [2 ]
Newbold, Lynne S. [1 ]
Anderson, Annaliesa S. [2 ]
Borrow, Ray [1 ]
机构
[1] Manchester Royal Infirm, Publ Hlth England, Vaccine Evaluat Unit, Clinical Sci Bldg 2, Manchester M13 9WZ, Lancs, England
[2] Pfizer Vaccine Res, 401 N Middletown Rd, Pearl River, NY 10965 USA
[3] Manchester Metropolitan Univ, John Dalton Bldg,Chester St, Manchester M1 5GD, Lancs, England
基金
英国惠康基金;
关键词
Neisseria meningitidis; Factor H-binding protein; Meningococcal vaccines; DNA sequencing; B NEISSERIA-MENINGITIDIS; SEROGROUP-B; QUANTITATIVE ASSESSMENT; VACCINE CANDIDATE; STRAIN COVERAGE; SEQUENCE TYPE; DISEASE; ENGLAND; WALES; IMMUNOGENICITY;
D O I
10.1016/j.jinf.2016.03.012
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To compare the distribution of capsular groups and factor H-binding protein (fHBP) variants among meningococcal isolates and non-culture clinical specimens and to assess the representativeness of group B isolates amongst group B cases as a whole. Methods: A PCR sequencing assay was used to characterise fHBP from non-culture cases confirmed from January 2011 to December 2013. These were compared to genotypic data derived from whole genome analysis of isolates received during the same period. Results: Group W and Y strains were more common among isolates than non-culture strains. The distribution of fHBP variants among group B non-culture cases generally reflected that seen in the corresponding isolates. Nonetheless, the non-culture subset contained a greater proportion of fHBP variant 15/B44, associated with the ST-269 cluster sublineage. Conclusions: Differences in capsular group and fHBP distribution among culture and nonculture cases may be indicative of variation in strain viability, diagnostic practice, disease severity and/or clinical presentation. Future analyses combining clinical case information with laboratory data may help to further explore these differences. Group B isolates provide a good representation of group B disease in E&W and, therefore, can reliably be used in fHBP strain coverage predictions of recently-licensed vaccines. Crown Copyright (C) 2016 Published by Elsevier Ltd on behalf of The British Infection Association. All rights reserved.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 35 条
[1]  
Alan Agresti., 1990, Categorical data analysis
[2]   Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease [J].
Anderson, Annaliesa S. ;
Hao, Li ;
Jiang, Qin ;
Harris, Shannon L. ;
Jones, Thomas R. ;
Perez, John L. ;
York, Laura ;
Eiden, Joseph ;
Jansen, Kathrin U. .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (03) :471-479
[3]   Variation of the factor H-binding protein of Neisseria meningitidis [J].
Brehony, Carina ;
Wilson, Daniel J. ;
Maiden, Martin C. J. .
MICROBIOLOGY-SGM, 2009, 155 :4155-4169
[4]   Genotypic Analysis of Meningococcal Factor H-Binding Protein from Non-Culture Clinical Specimens [J].
Clark, Stephen A. ;
Lucidarme, Jay ;
Newbold, Lynne S. ;
Borrow, Ray .
PLOS ONE, 2014, 9 (02)
[5]   Neisseria meningitidis NaIP cleaves human complement C3, facilitating degradation of C3b and survival in human serum [J].
Del Tordello, Elena ;
Vacca, Irene ;
Ram, Sanjay ;
Rappuoli, Rino ;
Serruto, Davide .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (01) :427-432
[6]   Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines [J].
Donnelly, John ;
Medini, Duccio ;
Boccadifuoco, Giuseppe ;
Biolchi, Alessia ;
Ward, Joel ;
Frasch, Carl ;
Moxon, E. Richard ;
Stella, Maria ;
Comanducci, Maurizio ;
Bambini, Stefania ;
Muzzi, Alessandro ;
Andrews, William ;
Chen, Jie ;
Santos, George ;
Santini, Laura ;
Boucher, Philip ;
Serruto, Davide ;
Pizza, Mariagrazia ;
Rappuoli, Rino ;
Giuliani, Marzia Monica .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (45) :19490-19495
[7]   Effect of Factor H-Binding Protein Sequence Variation on Factor H Binding and Survival of Neisseria meningitidis in Human Blood [J].
Dunphy, Kathleen Y. ;
Beernink, Peter T. ;
Brogioni, Barbara ;
Granoff, Dan M. .
INFECTION AND IMMUNITY, 2011, 79 (01) :353-359
[8]   Meningococcal group B vaccines [J].
Findlow, Jamie .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (06) :1387-1388
[9]   Vaccine potential of the Neisseria meningitidis 2086 lipoprotein [J].
Fletcher, LD ;
Bernfield, L ;
Barniak, V ;
Farley, JE ;
Howell, A ;
Knauf, M ;
Ooi, P ;
Smith, RP ;
Weise, P ;
Wetherell, M ;
Xie, XL ;
Zagursky, R ;
Zhang, Y ;
Zlotnick, GW .
INFECTION AND IMMUNITY, 2004, 72 (04) :2088-2100
[10]   The changing and dynamic epidemiology of meningococcal disease [J].
Halperin, Scott A. ;
Bettinger, Julie A. ;
Greenwood, Brian ;
Harrison, Lee H. ;
Jelfs, Jane ;
Ladhani, Shamez N. ;
McIntyre, Peter ;
Ramsay, Mary E. ;
Safadi, Marco A. P. .
VACCINE, 2012, 30 :B26-B36